| Literature DB >> 27211817 |
Hao Zou1, Yunxia Liu2, Dong Wei1, Tao Wang1, Kun Wang1, Songquan Huang1, Lixin Liu1, Yuehua Li1, Jiayun Ge1, Xiao Li1, Hong Zhu1, Lianmin Wang1, Songling Zhao1, Xiaowen Zhang1, Lin Wang1.
Abstract
Emerging evidence has shown that leptin, an adipocyte-derived cytokine that is closely associated with obesity, play a significant role in carcinogenesis and tumorigenesis. However, its impact on gallbladder cancer (GBC) remains unclear. In this study, we firstly found that leptin and its functional receptor OB-Rb were significantly co-expressed in human GBC tissues and cell lines, the content of which were higher than those in normal human gallbladder tissues. Treatment with leptin promoted the proliferation, migration and invasion of GBC cells, which were attenuated by OB-Rb shRNA. Blocking in the G2/M period of cell cycle, increasing of MMP3 and MMP9, increasing of VEGF-C/D, activation of SOCS3/JAK2/p-STAT3 pathway was demonstrated after treatment with leptin. All of these positive responses were attenuated by OB-Rb receptor shRNA. Taken together, our findings suggest that leptin promoted the proliferation, migration and invasion of GBC cells by increasing OB-Rb expression through the SOCS3/JAK2/p-STAT3 signal pathway. Targeting the leptin/OB-Rb axis could be an attractive therapeutic strategy for treatment of GBC.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27211817 DOI: 10.3892/ijo.2016.3530
Source DB: PubMed Journal: Int J Oncol ISSN: 1019-6439 Impact factor: 5.650